Science Explorer Interactive view Map
Company · San Diego · United States

Halozyme Therapeutics (United States)

halozyme.com/homepage/default.aspxROR OpenAlex
World rank, all time
#31,970
of 42,892
Rank in United States
#6,825
of 8,685
Research works
137
▼ 10% vs 2013–17
Citations
3.5k
25.6 per fractional work
Top-10% rate
38.2%
record average 16.5%
Open access
39%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 3.99× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 1.72× its world share, 0 worksImmunology and Micro…Neuroscience: 0.40× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 11.59× its world share, 0 worksPharmacology, Toxico…Engineering: 0.01× its world share, 0 worksEngineeringMaterials Science: 1.11× its world share, 0 worksMaterials ScienceMathematics: 0.59× its world share, 0 worksMathematicsHealth Professions: 1.80× its world share, 1 worksHealth ProfessionsMedicine: 2.90× its world share, 7 worksMedicineEconomics, Econometrics and Finance: 3.14× its world share, 1 worksEconomics, Econometr…Psychology: 0.12× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 11.6×. Every wedge is a field page.

Who are the top researchers at Halozyme Therapeutics (United States)?

Ranked on the composite score, Daniel C. Maneval and Curtis B. Thompson lead among researchers whose main affiliation is Halozyme Therapeutics (United States).

  1. 1 Daniel C. Maneval United States · #624,176 worldwide 53 citations · 25 works
  2. 2 Curtis B. Thompson United States · #1,219,047 worldwide 25 citations · 16 works
All ranked researchers at Halozyme Therapeutics (United States)

Which keywords describe research at Halozyme Therapeutics (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Angiogenesis, Cell Signaling, Toll-like Receptors, Hyaluronan, Proteoglycans, Cancer and Metabolism.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Inflammation35▲ 11×12 topics
  2. Angiogenesis32▲ 57×5 topics
  3. Cell Signaling27▲ 58×2 topics
  4. Toll-like Receptors26▲ 111×2 topics
  5. Hyaluronan26▲ 689×1 topic
  6. Proteoglycans26▲ 689×1 topic
  7. Cancer24▲ 12×6 topics
  8. Metabolism16▲ 18×2 topics
  9. Tumor Microenvironment14▲ 28×5 topics
  10. Therapy14▲ 46×3 topics
  11. Obesity13▲ 13×2 topics
  12. FGF2113▲ 612×1 topic
  13. Fibroblast Growth Factor13▲ 612×1 topic
  14. Glycosylation10▲ 33×3 topics
  15. Immunotherapy10▲ 11×8 topics
  16. Chemotherapy6▲ 6.5×9 topics
  17. Tumor Targeting6▲ 35×3 topics
  18. Glycans6▲ 56×1 topic
  19. Immune System6▲ 14×1 topic
  20. Nanoparticles6▲ 3.1×5 topics
  21. Gene Therapy6▲ 16×3 topics
  22. Tumor Regression5▲ 44×2 topics
  23. Cancer Therapy5▲ 6.0×5 topics
  24. HIF-15▲ 50×1 topic
  25. Warburg Effect5▲ 50×1 topic
  26. Arginine Deprivation5▲ 79×1 topic
  27. Bacterial Therapy5▲ 79×1 topic
  28. Drug Delivery5▲ 7.1×4 topics
  29. Complications5▲ 6.5×3 topics
  30. Insulin Therapy5▲ 31×3 topics
  31. PET Imaging5▲ 15×4 topics
  32. Immunosuppression4▲ 27×2 topics
  33. Monoclonal Antibodies4▲ 22×3 topics
  34. Fibroblast Activation Protein4▲ 60×1 topic
  35. N-terminal Acetylation4▲ 60×1 topic
  36. Chitosan4▲ 51×1 topic
  37. Mucosal4▲ 101×1 topic
  38. Therapeutic Antibodies4▲ 22×2 topics
  39. Immunity4▲ 7.8×3 topics
  40. Thrombosis4▲ 12×3 topics

Which research topics does Halozyme Therapeutics (United States) publish most on?

By volume in 2022–2025: Proteoglycans and glycosaminoglycans research, Platelet Disorders and Treatments, Monoclonal and Polyclonal Antibodies Research and Botulinum Toxin and Related Neurological Disorders.

Proteoglycans and glycos…2Proteoglycans and glycosaminoglycans research: 2 fractional worksPlatelet Disorders and Treatments: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 1 fractional worksBotulinum Toxin and Related Neurological Disorders: 1 fractional worksHealth Systems, Economic Evaluations, Quality of Life: 1 fractional worksHER2/EGFR in Cancer Research: 0 fractional worksAdvanced Drug Delivery Systems: 0 fractional worksPatient Safety and Medication Errors: 0 fractional worksNanoparticle-Based Drug Delivery: 0 fractional worksCancer Treatment and Pharmacology: 0 fractional works
Cell BiologyHematologyRadiology, Nuclear Medicine and ImagingNeurology5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Proteoglycans and glycosaminoglycans research Cell Biology 2 works
  2. 2 Platelet Disorders and Treatments Hematology 1 works
  3. 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  4. 4 Botulinum Toxin and Related Neurological Disorders Neurology 1 works
  5. 5 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
  6. 6 HER2/EGFR in Cancer Research Oncology 0 works
  7. 7 Advanced Drug Delivery Systems Pharmaceutical Science 0 works
  8. 8 Patient Safety and Medication Errors Emergency Medical Services 0 works
  9. 9 Nanoparticle-Based Drug Delivery Biomaterials 0 works
  10. 10 Cancer Treatment and Pharmacology Oncology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available38.9%not open61.1%

World: 28% of research is openly available.

with international co-authors12.7%domestic only87.3%

World: 19% is written across borders.

How has Halozyme Therapeutics (United States)'s research output changed?

Output in 2018–2022 was 10% lower than in 2013–2017.

201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in San Diego

All research institutions in San Diego

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.